CN103221040B - 双硫仑制剂及用途 - Google Patents
双硫仑制剂及用途 Download PDFInfo
- Publication number
- CN103221040B CN103221040B CN201180054964.9A CN201180054964A CN103221040B CN 103221040 B CN103221040 B CN 103221040B CN 201180054964 A CN201180054964 A CN 201180054964A CN 103221040 B CN103221040 B CN 103221040B
- Authority
- CN
- China
- Prior art keywords
- disulfiram
- liposome
- cell
- copper
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Optics & Photonics (AREA)
- Nanotechnology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (6)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1020860.1 | 2010-12-09 | ||
GBGB1020860.1A GB201020860D0 (en) | 2010-12-09 | 2010-12-09 | Disulfiram formulation and uses thereof |
PCT/GB2011/052439 WO2012076897A1 (en) | 2010-12-09 | 2011-12-08 | Disulfiram formulation and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103221040A CN103221040A (zh) | 2013-07-24 |
CN103221040B true CN103221040B (zh) | 2016-07-06 |
Family
ID=43566902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180054964.9A Expired - Fee Related CN103221040B (zh) | 2010-12-09 | 2011-12-08 | 双硫仑制剂及用途 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20140037715A1 (zh) |
EP (1) | EP2648709B1 (zh) |
CN (1) | CN103221040B (zh) |
GB (1) | GB201020860D0 (zh) |
WO (1) | WO2012076897A1 (zh) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10864190B2 (en) | 2015-04-22 | 2020-12-15 | CeMM—FORSCHUNGSZENTRUM FÜR MOLEKULARE MEDIZIN GmbH | Combination of an antiandrogen with a vitamin K antagonist or with a gamma-glutamyl carboxylase inhibitor for the therapy of androgen receptor positive cancer |
US10195164B2 (en) * | 2015-05-13 | 2019-02-05 | Duke University | Use of disulfiram for inflammatory breast cancer therapy |
US20170049701A1 (en) * | 2015-08-05 | 2017-02-23 | Steven M. Kushner | Clustoidal multilamellar soy lecithin phospholipid structures for transdermal, transmucosal, or oral delivery, improved intestinal absorption, and improved bioavailability of nutrients |
GB201519643D0 (en) | 2015-11-06 | 2015-12-23 | Univ Wolverhampton | Disulfiram formulation |
EP3449919B1 (en) * | 2016-04-13 | 2024-05-01 | University of Wolverhampton | Method for treating pleuroperitoneal membrane cancers by locally injecting disulfiram preparation |
EP3311843A1 (en) | 2016-10-13 | 2018-04-25 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Compositions comprising dithiocarbamate and cyclodextrin |
EP3532039A4 (en) * | 2016-10-26 | 2020-07-15 | Cantex Pharmaceuticals, Inc. | TIMED ORAL DOSAGE SCHEDULE WITH DISULFIRAM AND METAL SALT AND ORAL UNIT DOSAGE FORMS WITH TIMELY RELEASE |
WO2018083481A1 (en) | 2016-11-03 | 2018-05-11 | Ucl Business Plc | Cancer therapy |
CN106377496A (zh) * | 2016-11-19 | 2017-02-08 | 诺马(北京)科技有限公司 | 一种抗癌症的经皮吸收制剂 |
CN106692971B (zh) * | 2017-01-17 | 2020-03-10 | 苏州大学 | 金纳米热放疗药物载体及其制备方法和应用 |
WO2019094053A1 (en) * | 2017-11-13 | 2019-05-16 | Duke University | Disulfiram and copper salt dosing regimen |
WO2019113724A1 (zh) * | 2017-12-11 | 2019-06-20 | 广州君赫生物科技有限公司 | 双硫仑的新应用 |
CN107737108B (zh) * | 2017-12-17 | 2018-06-26 | 姚蕾 | 一种治疗心肌梗死后心室重塑的口服药物组合物 |
CN108295091A (zh) * | 2018-02-26 | 2018-07-20 | 广州医科大学 | AgDT化合物的应用 |
CN109125346A (zh) * | 2018-08-14 | 2019-01-04 | 兰州大学 | 一种可再生的铜载体抗癌试剂及其应用 |
WO2021015300A1 (ja) | 2019-07-25 | 2021-01-28 | 学校法人東京理科大学 | 精神・神経系の疾患又は症状を治療し、予防し又は改善する剤 |
CN111135175B (zh) * | 2020-01-17 | 2022-09-16 | 中国医学科学院放射医学研究所 | Dsf-2在制备抗肿瘤和抗辐射药物中的应用 |
CN111494316B (zh) * | 2020-04-14 | 2021-05-18 | 山东大学 | 一种载双硫仑的纳米乳原位凝胶剂的制备方法及其应用 |
TW202214244A (zh) * | 2020-08-10 | 2022-04-16 | 國立彰化師範大學 | 具有協同抗癌功效之氯硝柳胺(Niclosamide)和雙硫侖(Disulfiram)醫藥組合物及其用途 |
CN114146073B (zh) * | 2020-09-07 | 2023-08-11 | 上海交通大学医学院 | 双硫仑在增强免疫反应中的应用 |
CN112263591A (zh) * | 2020-11-10 | 2021-01-26 | 中南大学 | 用于治疗癌症的组合物及其应用 |
CN114469995B (zh) * | 2021-06-30 | 2023-05-05 | 四川大学 | 一种治疗急性肾损伤的药物组合物及其制备方法和用途 |
CN114767871B (zh) * | 2022-04-19 | 2023-04-07 | 中国工程物理研究院机械制造工艺研究所 | 介孔硅载药体系及制备方法和介孔硅载药 |
CN115137703B (zh) * | 2022-06-08 | 2024-03-19 | 深圳先进技术研究院 | 载药微凝胶球、载药支架及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001017522A1 (en) * | 1999-09-08 | 2001-03-15 | Charlotte-Mecklenburg Hospital Authority Doing Business As Carolinas Medical Center | Method of treating cancer using tetraethyl thiuram disulfide |
WO2005009338A2 (en) * | 2003-05-14 | 2005-02-03 | Charlotte-Mecklenburg Hospital Authority D/B/A/ Carolinas Medical Center | Method of inhibiting atf/creb and cancer cell growth and pharmaceutical compositions for same |
WO2008068746A2 (en) * | 2006-12-04 | 2008-06-12 | Yeda Research And Development Co. Ltd. | Disulfiram doses and treatment regimen suitable for treatment of angiogenesis-dependent disorders |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
US4356108A (en) | 1979-12-20 | 1982-10-26 | The Mead Corporation | Encapsulation process |
US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
US6451341B1 (en) * | 1990-02-05 | 2002-09-17 | Thomas J. Slaga | Time release formulation of vitamins, minerals and other beneficial supplements |
US5489508A (en) * | 1992-05-13 | 1996-02-06 | University Of Texas System Board Of Regents | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
EP1014946B1 (en) * | 1997-09-18 | 2010-04-07 | Pacira Pharmaceuticals, Inc. | Sustained-release liposomal anesthetic compositions |
US20070148689A1 (en) * | 2000-04-03 | 2007-06-28 | Kathryn Leishman | Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases |
US20050095283A1 (en) * | 2003-09-16 | 2005-05-05 | Aphios Corporation | Compositions and methods for topically treating diseases |
WO2007033110A2 (en) * | 2005-09-12 | 2007-03-22 | Alza Corporation | Liposomes for treatment of multiple myeloma |
US7794758B2 (en) * | 2007-04-05 | 2010-09-14 | Pmc Formulas, Inc. | Compounds and methods for promoting cellular health and treatment of cancer |
CA2697042A1 (en) * | 2007-08-21 | 2009-02-26 | Alza Corporation | Liposome compositions for in vivo administration of boronic acid compounds |
US9844656B2 (en) * | 2010-03-01 | 2017-12-19 | The Regents Of The University Of California | Localization of agents at a target site with a composition and an energy source |
-
2010
- 2010-12-09 GB GBGB1020860.1A patent/GB201020860D0/en not_active Ceased
-
2011
- 2011-12-08 US US13/991,608 patent/US20140037715A1/en not_active Abandoned
- 2011-12-08 WO PCT/GB2011/052439 patent/WO2012076897A1/en active Application Filing
- 2011-12-08 EP EP11808284.1A patent/EP2648709B1/en active Active
- 2011-12-08 CN CN201180054964.9A patent/CN103221040B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001017522A1 (en) * | 1999-09-08 | 2001-03-15 | Charlotte-Mecklenburg Hospital Authority Doing Business As Carolinas Medical Center | Method of treating cancer using tetraethyl thiuram disulfide |
WO2005009338A2 (en) * | 2003-05-14 | 2005-02-03 | Charlotte-Mecklenburg Hospital Authority D/B/A/ Carolinas Medical Center | Method of inhibiting atf/creb and cancer cell growth and pharmaceutical compositions for same |
WO2008068746A2 (en) * | 2006-12-04 | 2008-06-12 | Yeda Research And Development Co. Ltd. | Disulfiram doses and treatment regimen suitable for treatment of angiogenesis-dependent disorders |
Non-Patent Citations (3)
Title |
---|
Diethyldithiocarbamate may enhance the antitumor effect of adriamycin nanoparticle-lipiodol emulsion;吴道澄等;《Chinese Journal of Cancer Research》;20021231;第14卷(第3期);第192-194页 * |
Drug delivery by nanoparticles – facing the obstacles;M. Löbler等;《IFMBE Proceedings》;20081231;第22卷(第1期);第2335-2338页 * |
Preventiv Effect of Eye Drops of Liposomes Containing Disulfiram and Cefmetazole on Selenite-Induced Cataract in Rat Pups;Yoshimasa ITo等;《Journal of Oleo Science》;20061231;第55卷(第1期);第17页第2.4节 * |
Also Published As
Publication number | Publication date |
---|---|
WO2012076897A1 (en) | 2012-06-14 |
GB201020860D0 (en) | 2011-01-26 |
CN103221040A (zh) | 2013-07-24 |
EP2648709A1 (en) | 2013-10-16 |
US20140037715A1 (en) | 2014-02-06 |
EP2648709B1 (en) | 2019-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103221040B (zh) | 双硫仑制剂及用途 | |
EP2246056B1 (en) | Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation | |
CN103083239B (zh) | 一种蟾毒灵脂质体及其制备方法和应用 | |
JP2006513984A (ja) | 医薬的に活性な、脂質をベースにしたsn38製剤 | |
Shi et al. | Oxidative stress-driven DR5 upregulation restores TRAIL/Apo2L sensitivity induced by iron oxide nanoparticles in colorectal cancer | |
Long et al. | Azo-inserted responsive hybrid liposomes for hypoxia-specific drug delivery | |
CN113322065B (zh) | 一种荧光碳量子点及其制备方法和在制备抗肿瘤药物增敏剂中的用途 | |
ES2952680T3 (es) | Eribulina para inhibir el crecimiento tumoral | |
CN108495619A (zh) | 棘霉素制剂及其制备方法和使用方法 | |
CN112933045B (zh) | 共载双氢青蒿素/磷酸氯喹双敏感纳米制剂及其制备方法 | |
CN104490786B (zh) | 一种靶向多功能双载药脂质体的制备方法和应用 | |
US20240074974A1 (en) | Methods and related compositions for the treatment of cancer | |
US9937261B2 (en) | Combination therapy comprising a liposomal prodrug of mitomycin C and radiotherapy | |
EA018636B1 (ru) | Система доставки лекарственного средства для введения водорастворимого катионного и амфифильного фармацевтически активного вещества | |
MX2010009794A (es) | Uso combinado de un derivado de colestanol. | |
CN102085189B (zh) | 一种多西他赛长循环脂质体的制备方法 | |
CN104546722B (zh) | 米铂脂质体和制法 | |
Duan et al. | Reallocating Cell Respiration Substrates for Cancer Therapy Using a Metabolism Regulator with an Intermembrane‐Translocatable Accessory | |
CN110548006B (zh) | 一种科罗索酸脂质体及其制备方法和用途 | |
US20200368170A1 (en) | A lipid nanoparticle composition and a pharmaceutical composition for treating a hematoproliferative disorder | |
US10639372B2 (en) | Nucleic acid, medical nanoparticle, and pharmaceutical composition thereof | |
WO2024111564A1 (ja) | トポテカン又はその塩を内包するリポソーム組成物およびdna損傷修復阻害剤を含む組合せ医薬 | |
RU2519186C2 (ru) | Производное соединение холестанола для комбинированного применения | |
CN106138036A (zh) | 抗坏血酸棕榈酸酯在制备抗肿瘤药物中的应用 | |
TW202434243A (zh) | 含有內含拓普替康或其鹽之脂質體組成物及dna損傷修復抑制劑之組合醫藥 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Wu Chunfu Inventor after: Wang Weiguang Inventor after: Tang Xing Inventor after: Yang Jingyu Inventor after: Wang Lihui Inventor after: Wang Fang Inventor after: Zhang Yu Inventor before: Wu Chunfu Inventor before: Tang Xing Inventor before: Yang Jingyu Inventor before: Wang Lihui Inventor before: Wang Fang Inventor before: Zhang Yu |
|
COR | Change of bibliographic data | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160706 Termination date: 20201208 |